Approvals of New Prescription Drugs at Risk in Shutdown – WSJ

http://bit.ly/2U09BHG

wsj.com

200) && (this.width >= this.height) ? 200: true); max-height: 200px; height: expression((this.height > 200) && (this.height >= this.width) ? 200: true); border: none;’/>

The FDA is set to run out of money early next month to evaluate new prescription drugs if the government shutdown continues, potentially slowing the release of new prescription therapies.

posted by friends:
 (2)

@WSJRisk: The FDA is set to run out of money early next month to evaluate new prescription drugs if the government shutdown continues, potentially slowing the release of new therapies including cancer treatments.
on.wsj.com/2FHPU3i

18.01.2019 21.24.03

@WSJ: The FDA is set to run out of money early next month to evaluate new prescription drugs if the government shutdown continues on.wsj.com/2Dm5EHF

18.01.2019 21.00.12

@WSJRisk: Federal government shutdown threatens to dry up approvals of new prescription drugs on.wsj.com/2DkvYC0

18.01.2019 19.59.05

posted by followers of the list:
 (0)

Vía All News on ‘The Twitter Times: v/2019’ https://on.wsj.com/2FLH4l5

http://bit.ly/2FGYtvn